Alibaba probe unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers
For eight years, Chinese online retailer Alibaba and its U.S. payment processing company failed to prevent dangerous drugs, chemicals and pill presses from being sold to American customers -- even…
Read the full articleYou might also wanna read
Alibaba to pay $600 million to settle U.S. lawsuit over illegal drug sales on its platforms
Alibaba reached a massive financial settlement with the U.S. government to resolve accusations that the company allowed the sale and importa
fox5dc.com·5d ago
Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
WASHINGTON (AP) — The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that t
stcatharinesstandard.ca·8d ago
U.S. launches tariff probe into Germany's pharmaceutical pricing policies
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
cnbc.com·20d ago
U.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
The Economist·19d agoU.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
economist.com·19d ago
U.S. restrictions on Chinese biotechnology could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
econ.st·20d ago
Independent US body finds drug shortages are lasting longer as reliability dwindles
The US Pharmacopeia’s new sweeping report shows shortages are lingering as supply lines falter.
Comments
Sign in to join the conversation.
No comments yet. Be the first.